Dr. Frederick P. Smith is a medical oncologist specializing in breast cancer at Sibley Memorial Hospital and an instructor at Johns Hopkins School of Medicine and Georgetown University School of Medicine. He has a private practice in Washington, D.C. He is affiliated with Sibley Memorial Hospital and Suburban Hospital. Dr. Smith earned his medical degree from Saint Louis University School of Medicine. He completed a residency in internal medicine at Georgetown University Hospital, followed by a fellowship in oncology. Dr. Smith was named a 2012 Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly, as well as a Top MD by Consumers’ Checkbook Magazine. Prior to joining Johns Hopkins, Dr. Smith was the director of extramural oncology research at Georgetown University. In this position, he contributed over 50 articles to peer-reviewed medical journals. Dr. Smith is an integral advocate in the community for promoting access to clinical research. He has also contributed to clinical trials. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor.

Richard Mahon is a Pulmonary Medicine provider in Lanham, Maryland. Dr. Mahon is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Asthma in Children, Lung Metastases, Asthma, Pneumonia, and Orchiectomy. Dr. Mahon is currently accepting new patients.

Laeeq Ahmad is a General Surgeon in Lanham, Maryland. Dr. Ahmad is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are End-Stage Renal Disease (ESRD), Arterial Embolism, Peripheral Artery Disease, Carotid Artery Surgery, and Gastrostomy.

Fozia Abdulwahabe is a primary care provider, practicing in Internal Medicine in Lanham, Maryland. Dr. Abdulwahabe is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Memory Loss, Lung Metastases, Ascites, Gastrostomy, and Endoscopy. Dr. Abdulwahabe is currently accepting new patients.

Lipishree Nayak is a primary care provider, practicing in Family Medicine and Internal Medicine in Lanham, Maryland. Dr. Nayak is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Endoscopy, and Gastrostomy. Dr. Nayak is currently accepting new patients.

Chitra Venkatraman is a Hematologist Oncology specialist and a Hematologist in Greenbelt, Maryland. Dr. Venkatraman is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Anemia, and Breast Cancer. Dr. Venkatraman is currently accepting new patients.

Xiaoyan Wang is a Hematologist and an Oncologist in Greenbelt, Maryland. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Anemia, Pulmonary Embolism, Sickle Cell Disease, and Deep Vein Thrombosis. Dr. Wang is currently accepting new patients.

Patrick Cross is an Oncologist and a Hematologist in Greenbelt, Maryland. Dr. Cross is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, and Pancreatic Cancer. Dr. Cross is currently accepting new patients.

Cecil George is a primary care provider, practicing in Internal Medicine in Greenbelt, Maryland. Dr. George is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Hyperhidrosis, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. George is currently accepting new patients.

Monica Peravali is a Hematologist Oncology specialist and a Hematologist in Largo, Maryland. Dr. Peravali is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Heart Tumor, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Cancer. Dr. Peravali is currently accepting new patients.

Jeet Lund is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Largo, Maryland. Dr. Lund is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are COVID-19, Lymphofollicular Hyperplasia, Lung Nodules, Venous Thromboembolism (VTE), and Gastrostomy.

Elizabeth Pfaffenroth is a Hematologist Oncology specialist and a Hematologist in Largo, Maryland. Dr. Pfaffenroth is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Pfaffenroth is currently accepting new patients.

Revathy Murthy is a Pulmonary Medicine provider in Cheverly, Maryland. Dr. Murthy is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Neurosarcoidosis, and Sarcoidosis. Dr. Murthy is currently accepting new patients.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.

Andrew Lerner, M.D., is a clinical instructor of medicine in the pulmonary and critical care medicine department at the Johns Hopkins University School of Medicine, as well as the director of interventional pulmonology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. He practices out of Sibley Memorial Hospital in Washington, D.C. Dr. Lerner is part of the Sibley Memorial Hospital Lung Nodule and Lung Cancer Screening Clinic, the Multidisciplinary Pulmonary and Thoracic Surgery Clinic, and the Multidisciplinary Thoracic Tumor Board Conference. Dr. Lerner has an expertise in minimally invasive procedures for the early diagnosis and treatment of malignant and non-malignant diseases of the airways, lungs and pleura. He is experienced in advanced diagnostic and therapeutic bronchoscopy, including endobronchial ultrasound (EBUS) bronchoscopy, navigational bronchoscopy, rigid bronchoscopy, tumor ablative techniques, airway stent placement, airway dilation, radial EBUS, conventional transbronchial needle aspiration (TBNA), bronchial thermoplasty, whole lung lavage and percutaneous lung biopsy; as well as percutaneous tracheostomy, tunneled pleural catheter placement, thoracentesis, tube thoracoscopy, medical thoracoscopy, chemical pleurodesis and upper endoscopy (EGD/PEG) placement. Dr. Lerner earned his medical degree from George Washington University School of Medicine. He completed his residency in internal medicine at Thomas Jefferson University Hospital, followed by a fellowship in pulmonary and critical care medicine at the University of California, San Diego. Dr. Lerner then completed a two-year advanced fellowship in interventional pulmonology at The Johns Hopkins Hospital, including a chief fellowship year. He has been involved in multiple research projects in the field and completed a Science of Clinical Investigation Certificate Program at Johns Hopkins University Bloomberg School of Public Health. Dr. Lerner has been a member of the Alpha Omega Alpha medical honors society since 2011 and earned The Johns Hopkins Hospital Patient Safety Star Award in 2016. Dr. Lerner has contributed to numerous presentations, lectures, publications, book chapters and abstracts. He is a reviewer for several research journals. Dr. Lerner has various research interests and is currently involved in research projects focusing on EBUS bronchoscopy, lung cancer diagnosis and staging, and other topics. Confidential email to reach Dr. Lerner for any questions: alerner@jhu.edu. Dr. Lerner is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Nodules, Lymphofollicular Hyperplasia, Pleurisy, and Pleural Effusion.

Stephen R. Broderick, M.D., MPHS, is an assistant professor of surgery at Johns Hopkins University School of Medicine and a thoracic surgeon, part of a multidisciplinary team treating lung cancer patients in the Johns Hopkins Kimmel Cancer Center. Listen to Dr. Broderick's Cancer Matters podcast episode to learn more about his work. Dr. Broderick's primary clinical focus is at Sibley Memorial Hospital, in Washington, D.C. He also practices at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland. Dr. Broderick has a clinical expertise in surgical treatment of lung cancer, esophageal cancer and other thoracic malignancies, as well as benign thoracic conditions. This includes achalasia, bronchoscopy, chest wall reconstruction and tumors, lung nodules and paraesophageal hernias. He has a clinical interest in minimally invasive surgery for lung cancer and the coordinated delivery of multidisciplinary care for thoracic oncology patients. Before joining Johns Hopkins, Dr. Broderick was a thoracic surgeon at St Luke’s Hospital, where he served as the medical director of the cardiothoracic intensive care unit and a member of the oncology steering committee. He also served as an instructor of surgery at Washington University School of Medicine. Dr. Broderick received his medical degree from Georgetown University School of Medicine in 2003 and he completed his internship and residency training in general surgery at New York-Presbyterian Hospital. He studied the molecular biology of lung cancer as a research fellow at Memorial Sloan Kettering Cancer Center, where he received the Chairman's Award for outstanding contributions to the basic science research fellowship. Dr. Broderick also completed a fellowship in thoracic surgery at Washington University School of Medicine in 2012 and earned a Masters in Population Health Science from Washington University School of Medicine in 2014. Dr. Broderick is a member of the American College of Chest Physicians, The Society of Thoracic Surgeons and the American Society of Clinical Oncology. Dr. Broderick’s research interests are focused on improving outcomes for lung cancer patients. He is particularly interested in studying how various treatments for early-stage lung cancer impact patients’ quality of life. Dr. Broderick has contributed to numerous publications and is a reviewer for the Journal of Cardiovascular and Thoracic Surgery, as well as Annals of Thoracic Surgery. Dr. Broderick is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Tubal Ligation, and Lung Transplant.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Dr. Susan Scott is a thoracic medical oncologist with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. Dr. Scott has expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and pulmonary carcinoid tumors, as well as thymic malignancies. She leads the EGFR and HER2 lung cancer research program for Johns Hopkins. Dr. Scott received her undergraduate education at the University of Oxford, UK and medical doctorate from Yale University. She completed residency at the Cleveland Clinic where she also served as Chief Resident in Internal Medicine. Dr. Scott joined Johns Hopkins Oncology for fellowship training in Baltimore and was recruited to the thoracic oncology program to continue work as a physician and clinical scientist focused in lung cancer. Dr. Scott and her team are committed to providing compassionate and individualized care to their patients, including state-of-the-art therapies and clinical trials. Her research interests include clinical trials in resectable lung cancer, innovative applications of immunotherapy, and novel targeted therapies, especially EGFR- and HER2-mutated lung cancers. Dr. Scott is a member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC). Dr. Scott is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer.

Courtney Ackerman is a Hematologist Oncology specialist and a Hematologist in Silver Spring, Maryland. Dr. Ackerman has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, Iron Deficiency Anemia, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Ackerman is currently accepting new patients.